Stay updated on Pediatric Ph+ CML Clinical Trial.
Sign up to get notified when there's something new on the Pediatric Ph+ CML Clinical Trial. page.

Latest updates to the Pediatric Ph+ CML Clinical Trial. page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check21 days agoChange DetectedAdded a note that publications are automatically filled in from PubMed and updated the revision tag to v3.3.1, replacing the previous v3.2.0 wording.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the temporary funding-operational notice; the page now presents standard trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedBoth screenshots show the same Study Details page for NCT01844765 with no evident additions or deletions to core content. No critical information appears to have changed.SummaryDifference0.3%

- Check71 days agoChange Detected- Updated to v3.2.0 with a new operating-status notice about government funding. - Removed a specific topic: “Myeloproliferative neoplasm.”SummaryDifference2%

- Check79 days agoChange DetectedUpdated disease notation from bcr-abl1 positive to BCR-ABL1 positive and upgraded the revision from v3.0.2 to v3.1.0; this reflects formatting normalization and a minor version update without changing core meaning.SummaryDifference0.1%

Stay in the know with updates to Pediatric Ph+ CML Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the Pediatric Ph+ CML Clinical Trial. page.